Fusion Pharmaceuticals Appoints Life Science Industry Leaders Jeremy Bender, Teresa Bitetti and David Meek to its Board of Directors

HAMILTON, ON and BOSTON, Oct. 16, 2023 /PRNewswire/ -- Fusion Pharmaceuticals Inc. , a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision...

Related Keywords

Boston ,Massachusetts ,United States ,Colorado ,Wellesley College ,Canada ,America ,John Valliant ,Chau Khuong ,Sutro Biopharma ,Jeremy Bender ,Johan Christenson ,Teresa Bitetti ,Heather Preston ,Mereo Biopharma ,Amanda Cray ,Corporate Development ,Boston Consulting Group ,Niowave Inc ,Stanford University ,Investor Relations Corporate Communications ,Fusion Pharmaceuticals ,European Federation Of Pharmaceutical Industries Associations ,Prnewswire Fusion Pharmaceuticals Inc ,Mobil Oil Corporation ,Gilead Sciences ,Corporate Development At Allos Therapeutics ,Astrazeneca ,Novartis Pharmaceuticals Corporation ,Sloan School Of Management ,University Of Cincinnati ,Bristol Myers Squibb Company ,Darden School Of Business ,University Of Colorado ,Nasdaq ,Research Manufacturers Of America ,Oncology At Baxalta Incorporated ,University Of Virginia ,David Meek ,Fusion Chief Executive Officer John Valliant ,Chief Executive Officer ,Day One Biopharmaceuticals ,Vice President ,Chief Operating Officer ,Tizona Therapeutics ,Chief Business Officer ,Allos Therapeutics ,Independent Board ,Biological Sciences ,Global Oncology Business Unit ,Senior Vice President ,Worldwide Oncology ,General Manager ,Worldwide Head ,Mobil Oil ,Osmol Therapeutics ,Darden School ,Board Member ,Executive Vice President ,Baxalta Incorporated ,Chief Commercial Officer ,Pharmaceutical Research ,European Federation ,Pharmaceutical Industries ,Entasis Therapeutics ,Response Inhibitors ,Investor Relations ,Markets ,